Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies

Authors

Institutions

Publication Details

Journal
Rheumatology and Therapy
Published
2026-03-13
DOI
https://doi.org/10.1007/s40744-026-00834-5
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies

Marina Magrey, Victoria S. Jasion, K. Kato, Ana Biljan et al.
Rheumatology and Therapy
Spondyloarthritis Studies and Treatments
article

Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies

Marina Magrey, Victoria S. Jasion, K. Kato, Ana Biljan, Ralph Lippe, Tianming Gao, Jamie Urbanik, Louis Bessette, Xenofon Baraliakos, Kurt de Vlam, Peter C. Taylor
article en

Abstract

No abstract available for this paper.
Rheumatology and Therapy
University Hospitals of Cleveland (US), Nuffield Orthopaedic Centre (GB), AbbVie (United States) (US), University of Oxford (GB), Rheumazentrum Ruhrgebiet (DE), Université Laval (CA), KU Leuven (BE)
Openalex Percentile: Top 22%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.